Qiagen N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
02 feb 2016 - 21:46
Statutaire naam
Qiagen N.V.
Titel
QIAGEN reports results for fourth quarter and full-year 2015
Bericht
QIAGEN reports results for fourth quarter and full-year 2015
FY 2015: Adjusted net sales $1.28 billion (+3% at constant exchange rates, -5% actual); adjusted operating income $315 million; adjusted EPS $1.05 ($1.13 CER)
Adjusted net sales rise 6% CER excluding three percentage points of headwind from reduced U.S. HPV test sales
Free cash flow rises 9% to $220 million
Q4 2015: Adjusted net sales $349 million (+3% CER, -3% actual); adjusted operating income $90 million; adjusted EPS $0.31 ($0.33 CER)
Growth drivers at forefront of solid underlying performance in 2015, delivering double-digit CER growth and one-third of sales
QIAGEN expects higher full-year 2016 adjusted net sales and earnings at CER
Gerelateerde downloads
Datum laatste update: 14 maart 2026